GTF2H2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.956800E-01
Normal-vs-Stage2
6.896000E-01
Normal-vs-Stage3
5.499000E-01
Normal-vs-Stage4
5.610000E-01
Stage1-vs-Stage2
8.991800E-01
Stage1-vs-Stage3
7.176400E-02
Stage1-vs-Stage4
7.583400E-01
Stage2-vs-Stage3
2.794400E-01
Stage2-vs-Stage4
7.119400E-01
Stage3-vs-Stage4
2.115800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.452200E-01
Normal-vs-AfricanAmerican
7.478600E-01
Normal-vs-Asian
2.075200E-01
Caucasian-vs-AfricanAmerican
8.636600E-01
Caucasian-vs-Asian
5.96480000000232E-05
AfricanAmerican-vs-Asian
1.362180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.240000E-01
Normal-vs-Female
7.830600E-01
Male-vs-Female
3.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.376400E-01
Normal-vs-Age(41-60Yrs)
6.141400E-01
Normal-vs-Age(61-80Yrs)
7.517600E-01
Normal-vs-Age(81-100Yrs)
7.277200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.562200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.891600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.568200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.554600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.526400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.598400E-01
Normal-vs-Daily Drinker
8.845800E-01
Normal-vs-Weekly Drinker
7.143600E-01
Normal-vs-Occasional Drinker
3.499600E-01
Normal-vs-Social Drinker
5.444200E-01
Non Drinker-vs-Daily Drinker
9.139000E-01
Non Drinker-vs-Weekly Drinker
6.437000E-01
Non Drinker-vs-Occasional Drinker
2.069800E-01
Non Drinker-vs-Social Drinker
1.534030E-01
Daily Drinker-vs-Weekly Drinker
5.803800E-01
Daily Drinker-vs-Occasional Drinker
1.518970E-01
Daily Drinker-vs-Social Drinker
2.228800E-01
Weekly Drinker-vs-Occasional Drinker
5.767800E-01
Weekly Drinker-vs-Social Drinker
1.596600E-01
Occasional Drinker-vs-Social Drinker
6.504500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.836400E-01
Normal-vs-Grade 2
7.391000E-01
Normal-vs-Grade 3
6.845000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.283170E-01
Grade 1-vs-Grade 3
9.825000E-01
Grade 1-vs-Grade 4
6.836400E-01
Grade 2-vs-Grade 3
1.608400E-01
Grade 2-vs-Grade 4
7.391000E-01
Grade 3-vs-Grade 4
6.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.601600E-01
Normal-vs-NonDiabetic
8.129000E-01
Diabetic-vs-NonDiabetic
9.991400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.074600E-01
Normal-vs-NoPancreatitis
7.627200E-01
Pancreatitis-vs-NoPancreatitis
6.768800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.427200E-01
Normal-vs-N1
7.037600E-01
N0-vs-N1
8.892000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.857400E-01
Normal-vs-TP53-NonMutant
6.793200E-01
TP53-Mutant-vs-TP53-NonMutant
5.491700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
